VTAMA® (tapinarof) CREAM, 1%
VTAMA cream is the first non-steroidal topical novel chemical entity launched for plaque psoriasis in the U.S. in more than 25 years.
For more information, visit the VTAMA cream website.
Ask your healthcare provider if VTAMA cream is right for you.
Everyone deserves healthy skin
Dermavant is committed to helping patients access the treatment they need.
Not an actual patient
Dermavant Savings & Resources
Dermavant offers resources to help patients locate a dermatologist, find information on savings for commercially insured patients and more.
Learn More
Dermavant RxAssist™
Dermavant RxAssist is a program that can help eligible patients gain access to our medication at no cost.*
Learn More
*Subject to financial eligibility requirements. Other terms and restrictions apply.
You are now leaving Dermavant.com
You are now leaving www.dermavant.com. Links to sites outside of Dermavant are provided as a resource to the viewer. Dermavant accepts no responsibility for the content of linked sites.
You are now leaving Dermavant.com
You are now leaving www.dermavant.com. Links to sites outside of Dermavant are provided as a resource to the viewer. Dermavant accepts no responsibility for the content of linked sites.
You are now leaving Dermavant.com
You are now leaving www.dermavant.com. Links to sites outside of Dermavant are provided as a resource to the viewer. Dermavant accepts no responsibility for the content of linked sites.
You are now leaving Dermavant.com
You are now leaving www.dermavant.com. Links to sites outside of Dermavant are provided as a resource to the viewer. Dermavant accepts no responsibility for the content of linked sites.
You are now leaving Dermavant.com
You are now leaving www.dermavant.com. Links to sites outside of Dermavant are provided as a resource to the viewer. Dermavant accepts no responsibility for the content of linked sites.
You are now leaving Dermavant.com
You are now leaving www.dermavant.com. Links to sites outside of Dermavant are provided as a resource to the viewer. Dermavant accepts no responsibility for the content of linked sites.
Important Safety Information
Indication: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of plaque psoriasis in adults. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in subjects treated with VTAMA cream were folliculitis (red raised bumps around the hair pores), nasopharyngitis (pain or swelling in the nose and throat), contact dermatitis (skin rash or irritation, including itching and redness, peeling, burning, or stinging), headache, pruritus (itching), and influenza (flu).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.